Abstract: The present disclosure relates to methods of treating a tumor with a nucleotide vaccine (e.g., DNA vaccine encoding a tumor antigen) in combination with an IL-7. In some aspects, the IL-7 is administered after the administration of the nucleotide vaccine (e.g., after the peak expansion phase of the tumor-specific T cell immune response) or concurrently with the nucleotide vaccine.

Abstract: The present disclosure relates to a display device including a first substrate including an active area and a non-active area which encloses the active area, a display unit disposed on an upper surface of the first substrate, an encapsulation unit which covers the display unit, a touch panel disposed on the encapsulation unit, an adhesive layer which bonds the touch panel and the first substrate, and a polarizer disposed on the touch panel, the touch panel includes a plurality of touch insulating layers and a touch electrode and ends of the plurality of touch insulating layers are spaced apart from an end of the polarizer.

Abstract: A liquid crystal display (LCD) device is disclosed, which comprises a first substrate and a second substrate; a pixel electrode provided in each of the plurality of pixels on the first substrate; a common electrode provided on the first substrate; an auxiliary line connected to the common electrode; a column spacer provided between the first substrate and the second substrate; and moving stopper walls provided on the first substrate to restrict a moving range of the column spacer and spaced apart from the auxiliary line. As a moving range of the column spacer may be restricted by the moving stopper walls, an alignment direction of a liquid crystal layer is not changed by movement of the column spacer, whereby a spot defect of the LCD device may be avoided.

Abstract: A liquid crystal display (LCD) device is disclosed, which comprises a first substrate and a second substrate; a pixel electrode provided in each of the plurality of pixels on the first substrate; a common electrode provided on the first substrate; an auxiliary line connected to the common electrode; a column spacer provided between the first substrate and the second substrate; and moving stopper walls provided on the first substrate to restrict a moving range of the column spacer and spaced apart from the auxiliary line. As a moving range of the column spacer may be restricted by the moving stopper walls, an alignment direction of a liquid crystal layer is not changed by movement of the column spacer, whereby a spot defect of the LCD device may be avoided.

Abstract: A method of controlling an operation of a portable skin treatment device, the method including: if a control button of the treatment device is pressed, heating a heater to prepare heating of a tip of the treatment device in a predetermined temperature range; and if heating of the tip is completed, turning on a light source disposed inside a housing of the treatment device and performing light irradiation treatment of irradiating light onto the skin through the tip together with heat. By using the method of controlling the operation of the portable skin treatment device by applying heat to the skin area of a disease of sebaceous glands such as acne etc. or itch and by irradiating light onto the skin area, treatment effects can be improved, and the fact that a user is getting treatment can be more realistically recognized.